396 related articles for article (PubMed ID: 17189276)
1. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
2. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
[TBL] [Abstract][Full Text] [Related]
4. Theoretical analysis of microdosimetric spectra and cluster formation for 103Pd and 125I photon emitters.
Reniers B; Vynckier S; Verhaegen F
Phys Med Biol; 2004 Aug; 49(16):3781-95. PubMed ID: 15446805
[TBL] [Abstract][Full Text] [Related]
5. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric study of a new polymer encapsulated palladium-103 seed.
Bernard S; Vynckier S
Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
[TBL] [Abstract][Full Text] [Related]
7. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
Sadeghi M; Hosseini SH; Raisali G
Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
9. A permanent breast seed implant as partial breast radiation therapy for early-stage patients: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations.
Keller B; Sankreacha R; Rakovitch E; O'brien P; Pignol JP
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):358-65. PubMed ID: 15890575
[TBL] [Abstract][Full Text] [Related]
10. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
Duggan DM
Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
[TBL] [Abstract][Full Text] [Related]
11. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed.
Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM
Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
Sowards KT
J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric characteristic of a new 125I brachytherapy source.
Sadeghi M; Khanmohammadi Z
Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
[TBL] [Abstract][Full Text] [Related]
14. Microdosimetric Evaluation of Current and Alternative Brachytherapy Sources-A Geant4-DNA Simulation Study.
Famulari G; Pater P; Enger SA
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):270-277. PubMed ID: 29102279
[TBL] [Abstract][Full Text] [Related]
15. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
Nuttens VE; Lucas S
Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
17. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
[TBL] [Abstract][Full Text] [Related]
18. A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function.
Wuu CS; Zaider M
Med Phys; 1998 Nov; 25(11):2186-9. PubMed ID: 9829243
[TBL] [Abstract][Full Text] [Related]
19. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
Wang Z; Hertel NE
Appl Radiat Isot; 2005 Sep; 63(3):311-21. PubMed ID: 15964196
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
Zilio VO; Joneja OP; Popowski Y; Chawla R
Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]